PDF EXAM
NURS 6501 Advanced
Pathophysiology Final Exam
(Walden University, Week 11,
2025/2026 Edition) – complete
exam with 100% score
Question 1
A 65-year-old patient with type 2 diabetes presents with chronic kidney
disease. Which molecular pathway is primarily dysregulated in the
podocyte injury leading to diabetic nephropathy?
A. Enhanced Wnt/β-catenin signaling B. Activation of the NLRP3
inflammasome C. Hyperglycemia-induced TGF-β/Smad signaling D.
Upregulation of mTORC1 in mesangial cells
Rationale: In diabetic nephropathy, hyperglycemia triggers TGF-
β/Smad signaling in podocytes, promoting fibrosis and effacement,
which is a hallmark of glomerular injury. This pathway is targeted in
emerging therapies like SGLT2 inhibitors, which modulate downstream
effects to preserve renal function, aligning with 2025 guidelines from the
American Diabetes Association.
Question 2
In a patient with acute respiratory distress syndrome (ARDS) secondary
to SARS-CoV-2 variant infection, what is the primary mechanism of
alveolar-capillary membrane disruption?
GRADED A+
, PDF EXAM
A. Neutrophil elastase-mediated basement membrane degradation B.
Endothelial glycocalyx shedding and glycocalyx degradation C. Type
II pneumocyte apoptosis via Fas/FasL pathway D. Excessive surfactant
protein B production
Rationale: The endothelial glycocalyx acts as a barrier; in COVID-19-
related ARDS, viral spike protein induces heparanase activity, leading to
shedding and increased vascular permeability. Recent 2026 studies
emphasize glycocalyx-targeted interventions, such as sulodexide, for
reducing ARDS mortality.
Question 3
A 45-year-old woman with systemic lupus erythematosus (SLE)
develops neuropsychiatric symptoms. Which autoantibody is most
strongly associated with lupus cerebritis via blood-brain barrier
disruption?
A. Anti-dsDNA B. Anti-Smith (anti-Sm) C. Anti-ribosomal P protein
D. Anti-cardiolipin
Rationale: Anti-ribosomal P antibodies cross-react with neuronal
antigens and promote blood-brain barrier permeability via cytokine
induction (e.g., IL-6), a mechanism elucidated in 2025 precision
immunology research. This association guides targeted B-cell therapies
like belimumab in SLE management.
Question 4
In the pathogenesis of Alzheimer's disease, what role does the gut-brain
axis play in amyloid-β plaque formation, based on 2025 microbiome
studies?
A. Increased short-chain fatty acid production enhances microglial
clearance B. Dysbiosis-induced LPS translocation promotes
neuroinflammation and Aβ aggregation C. Elevated butyrate levels
GRADED A+
, PDF EXAM
inhibit tau hyperphosphorylation D. Reduced Bacteroides species
decrease cholinergic signaling
Rationale: Gut dysbiosis in AD patients leads to lipopolysaccharide
(LPS) translocation, activating TLR4/NF-κB pathways in the brain,
exacerbating Aβ oligomerization. 2025 trials with fecal microbiota
transplantation show promise in modulating this axis for
neuroprotection.
Question 5
A 70-year-old man with Parkinson's disease exhibits L-DOPA-induced
dyskinesia. What is the underlying pathophysiological mechanism
involving striatal dopamine receptors?
A. D1 receptor hypersensitivity due to chronic denervation B. Aberrant
D1-D2 receptor heterodimerization in medium spiny neurons C.
Increased GABAergic inhibition from substantia nigra pars reticulata D.
Downregulation of vesicular monoamine transporter 2 (VMAT2)
Rationale: Long-term L-DOPA therapy promotes abnormal D1-D2
heterodimers in the direct pathway, leading to hypersynchronous
oscillations and dyskinesia. 2026 deep brain stimulation protocols target
this for improved motor control, as per recent neuromodulation
guidelines.
Question 6
In cystic fibrosis, the F508del-CFTR mutation primarily causes
defective anion transport. What secondary mechanism contributes to
mucociliary clearance failure in 2025 therapeutic contexts?
A. Upregulation of ENaC channels B. Impaired autophagy-lysosomal
degradation of aggregated CFTR C. Enhanced CFTR-independent
ClC-3 chloride channels D. Reduced mucin gene expression via FOXJ1
transcription factor
GRADED A+
NURS 6501 Advanced
Pathophysiology Final Exam
(Walden University, Week 11,
2025/2026 Edition) – complete
exam with 100% score
Question 1
A 65-year-old patient with type 2 diabetes presents with chronic kidney
disease. Which molecular pathway is primarily dysregulated in the
podocyte injury leading to diabetic nephropathy?
A. Enhanced Wnt/β-catenin signaling B. Activation of the NLRP3
inflammasome C. Hyperglycemia-induced TGF-β/Smad signaling D.
Upregulation of mTORC1 in mesangial cells
Rationale: In diabetic nephropathy, hyperglycemia triggers TGF-
β/Smad signaling in podocytes, promoting fibrosis and effacement,
which is a hallmark of glomerular injury. This pathway is targeted in
emerging therapies like SGLT2 inhibitors, which modulate downstream
effects to preserve renal function, aligning with 2025 guidelines from the
American Diabetes Association.
Question 2
In a patient with acute respiratory distress syndrome (ARDS) secondary
to SARS-CoV-2 variant infection, what is the primary mechanism of
alveolar-capillary membrane disruption?
GRADED A+
, PDF EXAM
A. Neutrophil elastase-mediated basement membrane degradation B.
Endothelial glycocalyx shedding and glycocalyx degradation C. Type
II pneumocyte apoptosis via Fas/FasL pathway D. Excessive surfactant
protein B production
Rationale: The endothelial glycocalyx acts as a barrier; in COVID-19-
related ARDS, viral spike protein induces heparanase activity, leading to
shedding and increased vascular permeability. Recent 2026 studies
emphasize glycocalyx-targeted interventions, such as sulodexide, for
reducing ARDS mortality.
Question 3
A 45-year-old woman with systemic lupus erythematosus (SLE)
develops neuropsychiatric symptoms. Which autoantibody is most
strongly associated with lupus cerebritis via blood-brain barrier
disruption?
A. Anti-dsDNA B. Anti-Smith (anti-Sm) C. Anti-ribosomal P protein
D. Anti-cardiolipin
Rationale: Anti-ribosomal P antibodies cross-react with neuronal
antigens and promote blood-brain barrier permeability via cytokine
induction (e.g., IL-6), a mechanism elucidated in 2025 precision
immunology research. This association guides targeted B-cell therapies
like belimumab in SLE management.
Question 4
In the pathogenesis of Alzheimer's disease, what role does the gut-brain
axis play in amyloid-β plaque formation, based on 2025 microbiome
studies?
A. Increased short-chain fatty acid production enhances microglial
clearance B. Dysbiosis-induced LPS translocation promotes
neuroinflammation and Aβ aggregation C. Elevated butyrate levels
GRADED A+
, PDF EXAM
inhibit tau hyperphosphorylation D. Reduced Bacteroides species
decrease cholinergic signaling
Rationale: Gut dysbiosis in AD patients leads to lipopolysaccharide
(LPS) translocation, activating TLR4/NF-κB pathways in the brain,
exacerbating Aβ oligomerization. 2025 trials with fecal microbiota
transplantation show promise in modulating this axis for
neuroprotection.
Question 5
A 70-year-old man with Parkinson's disease exhibits L-DOPA-induced
dyskinesia. What is the underlying pathophysiological mechanism
involving striatal dopamine receptors?
A. D1 receptor hypersensitivity due to chronic denervation B. Aberrant
D1-D2 receptor heterodimerization in medium spiny neurons C.
Increased GABAergic inhibition from substantia nigra pars reticulata D.
Downregulation of vesicular monoamine transporter 2 (VMAT2)
Rationale: Long-term L-DOPA therapy promotes abnormal D1-D2
heterodimers in the direct pathway, leading to hypersynchronous
oscillations and dyskinesia. 2026 deep brain stimulation protocols target
this for improved motor control, as per recent neuromodulation
guidelines.
Question 6
In cystic fibrosis, the F508del-CFTR mutation primarily causes
defective anion transport. What secondary mechanism contributes to
mucociliary clearance failure in 2025 therapeutic contexts?
A. Upregulation of ENaC channels B. Impaired autophagy-lysosomal
degradation of aggregated CFTR C. Enhanced CFTR-independent
ClC-3 chloride channels D. Reduced mucin gene expression via FOXJ1
transcription factor
GRADED A+
